Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 6,836 shares at $175.64 ($1.2M) on 2018-06-15, disclosed to the SEC on 2018-06-18.
Open-market sale of $1.2M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.64 | 1,235 | $217K | 17.9% |
| 2 | $177.12 | 5,601 | $992K | 82.1% |
| Total | $176.85 avg | 6,836 | $1.2M | 100% |
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-10-03 | $852K | — | Filing → |
| LOXO | SELL | 2018-06-18 | $992K | — | Filing → |